检索结果 - Michael K. Gibson

Refine Results
  1. 1
    Oesophageal carcinoma

    Oesophageal carcinoma 由 Arjun Pennathur, Michael K. Gibson, Blair A. Jobe, James D. Luketich

    出版 2013
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Interaction of p53 with the Human Rad51 Protein

    Interaction of p53 with the Human Rad51 Protein 由 Sabine Buchhop, Michael K. Gibson, Xin Wei Wang, P. Wagner, Horst-Werner Stürzbecher, C C Harris

    出版 1997
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful?

    Vision impairment following glucagon-like peptide-1 receptor agonist use: is it harmful? 由 Maria Cecilia Bahit, Michael K. Gibson, Martyna Kuleta, Łukasz Szarpak, Krzysztof Piotr Malinowski, Iwona Kowalska‐Bobko, Zbigniew Siudak

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes

    Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes 由 Roberto Gomez-Casal, Chitralekha Bhattacharya, Nandita Ganesh, Lisa A. Bailey, Per Basse, Michael K. Gibson, Michael W. Epperly, Vera Levina

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck

    Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck 由 Min Yao, Nicholas Galanopoulos, Pierre Lavertu, Pingfu Fu, Michael K. Gibson, Athanassios Argiris, Rod Rezaee, Chad Zender, Jay Wasman, Mitchell Machtay, P. Savvides

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer

    Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer 由 Brian A. Boone, Jennifer Steve, Alyssa M. Krasinskas, Amer H. Zureikat, Barry C. Lembersky, Michael K. Gibson, Ronald G. Stoller, Herbert J. Zeh, Nathan Bahary

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy

    Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy 由 Arjun Pennathur, Andrew Farkas, Alyssa M. Krasinskas, Peter F. Ferson, William E. Gooding, Michael K. Gibson, Matthew J. Schuchert, Rodney J. Landreneau, James D. Luketich

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    The Impact of Tumor Volume and Radiotherapy Dose on Outcome in Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck Treated With Stereotactic Body Radiation Therapy

    The Impact of Tumor Volume and Radiotherapy Dose on Outcome in Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck Treated With Stereotactic Body Radiation... 由 Jean-Claude M. Rwigema, Dwight E. Heron, Robert L. Ferris, Regiane S. Andrade, Michael K. Gibson, Yong Yang, Cihat Ozhasoglu, Athanassios Argiris, Jennifer R. Grandis, Steven A. Burton

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy

    Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy 由 Vida Almario Passero, Barton F. Branstetter, Y. Shuai, Dwight E. Heron, Michael K. Gibson, Stephen Y. Lai, S. W. Kim, Jennifer R. Grandis, Robert L. Ferris, Jonas T. Johnson, Athanassios Argiris

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer

    Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer 由 Harry H. Yoon, Zhaohui Jin, Oudom Kour, Lionel Aurelien Kankeu Fonkoua, Kohei Shitara, Michael K. Gibson, Larry J. Prokop, Markus Moehler, Yoon‐Koo Kang, Qian Shi, Jaffer A. Ajani

    出版 2022
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.

    The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. 由 Xin Wei Wang, Wim Vermeulen, Jill D. Coursen, Michael K. Gibson, Shawn E. Lupold, Kathleen Forrester, Guangwen Xu, Lynne W. Elmore, Heidi Yeh, Jan H.J. Hoeijmakers, C C Harris

    出版 1996
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma

    Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma 由 J.L. Geiger, Julie E. Bauman, Michael K. Gibson, William E. Gooding, Prakash Varadarajan, Athanasios Κotsakis, Daniel Martı́n, J. Silvio Gutkind, Matthew L. Hedberg, Jennifer R. Grandis, Athanassios Argiris

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Remote monitoring titration clinic to implement guideline-directed therapy for heart failure patients with reduced ejection fraction: a pilot quality-improvement intervention

    Remote monitoring titration clinic to implement guideline-directed therapy for heart failure patients with reduced ejection fraction: a pilot quality-improvement intervention 由 Erick Romero, Stella Yala, Camryn Sellers-Porter, Genevieve Lynch, Veronicah Mwathi, Yvette Hellier, Svetlana Goldman, Paulo Rocha, Jeffrey Fine, David Liem, Julie T. Bidwell, Imo Ebong, Michael K. Gibson, Martín Cadeiras

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck

    Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck 由 Athanassios Argiris, Athanasios Κotsakis, Tien Hoang, Francis P. Worden, P. Savvides, Michael K. Gibson, Rekha Gyanchandani, George R. Blumenschein, H.X. Chen, Jennifer R. Grandis, Paul M. Harari, M.S. Kies, S. Kim

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer

    Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Nec... 由 Athanassios Argiris, Dwight E. Heron, Ryan P. Smith, Seungwon Kim, Michael K. Gibson, Stephen Y. Lai, Barton F. Branstetter, Donna M. Posluszny, Lin Wang, Raja R. Seethala, Sanja Đačić, William E. Gooding, Jennifer R. Grandis, Jonas T. Johnson, Robert L. Ferris

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer

    Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer 由 Aleksandar Z. Obradovic, Diana Graves, Michael Korrer, Yu Wang, Sohini Roy, Abdullah Naveed, Yaomin Xu, Adam Luginbuhl, Joseph Curry, Michael K. Gibson, Kamran Idrees, Paula J. Hurley, Peng Jiang, X. Shirley Liu, Ravindra Uppaluri, Charles G. Drake, Andrea Califano, Young J. Kim

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

    Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study 由 Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister, Francis P. Worden, Stephen V. Liu, Jill Gilbert, Nabil F. Saba, Jared Weiss, Lori J. Wirth, Ammar Sukari, Hyunseok Kang, Michael K. Gibson, Erminia Massarelli, Steven Powell, Amy Meister, Xinxin Shu, Jonathan D. Cheng, Robert I. Haddad

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

    Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer 由 Athanassios Argiris, Julie E. Bauman, James Ohr, William E. Gooding, Dwight E. Heron, Umamaheswar Duvvuri, Gregory J. Kubicek, Donna M. Posluszny, Maria Vassilakopoulou, S. Kim, Jennifer R. Grandis, Jonas T. Johnson, Michael K. Gibson, D.A. Clump, John T. Flaherty, Simion I. Chiosea, Barton F. Branstetter, Robert L. Ferris

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Phase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours

    Phase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours 由 Aung Naing, Todd M. Bauer, K. Papadopoulos, Osama E. Rahma, Frank Tsai, Elena Garralda, Jarushka Naidoo, Sachin Gopalkrishna Pai, Michael K. Gibson, Igor I. Rybkin, Dee Dee Wang, David F. McDermott, Angelica Fasolo, Maria J. de Miguel, M. Shaheen, Yonchu Jenkins, Howard Kallender, Sven Gogov, Emil Kuriakose, Michael J. Pishvaian

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck

    Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck 由 Robert L. Ferris, Nabil F. Saba, Barbara J. Gitlitz, Robert I. Haddad, Ammar Sukari, Prakash Neupane, John C. Morris, Krzysztof Misiukiewicz, Julie E. Bauman, Moon J. Fenton, Antonio Jimeno, Douglas R. Adkins, Charles Schneider, Assuntina G. Sacco, Keisuke Shirai, Daniel W. Bowles, Michael K. Gibson, T. Nwizu, Raphaël Gottardo, Kristi L. Manjarrez, Gregory N. Dietsch, James Kyle Bryan, Robert M. Hershberg, Ezra E.W. Cohen

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: